The Weekly Scale: May 17th, 2021

This week at MarketScale, we hosted the first ever Dallas 100 draft, explored the future of last-mile delivery and solved this summer’s travel pain points, so you can sit back, relax and sip on your Mai Tai.

Go ahead and get yourself that supersized iced coffee. It’s the start of a new week, and it’s time to scale up.

With 500 million native Spanish speakers worldwide, we are seeing incredible growth in Spanish content delivery through streaming.

Voice of B2B Daniel Litwin sat down with Mrugesh Desai, Lead for the North American Region for Accedo, to discuss the usage patterns they have seen in Hispanic audiences and how that guides user experience design that helps potential audiences find the content they want.

Last-mile delivery is now essential in the logics space, and a Dallas 100 company wants to shake up the space.

CEO of PickUP Brenda Stoner joined us our in Trinity Studio to discuss how the last mile for smaller parcels is relatively commoditized, while larger product delivery was an unfilled niche.

What’s one of the biggest hurdles to scaling drones for delivery and other applications? Managing the sky.

Eyal Zor joins Grant Guillot on Drones in America to discuss how they are approaching utilizing AI to manage and scale unmanned traffic management systems that will help power the future of drone services.

Schools are yearning for multiple modalities, but the pandemic shifted the focus to high-end, high impact learning.

This week on the Voices of eLearning podcast, JW Marshall is joined by the host of Change Starts Here, Dustin Odham, to discuss how he and FranklinCovey are on a mission to create systems that ensure predictable outcomes for students and districts.

The MarketScale Hospitality Roundtable is back and, this time, we’re exploring How to Solve Travel’s Pain Points for Summer 2021.

The panel will include:

Jacob Wedderburn-Day, Stasher

Jeff Bonaldi, The Explorer’s Passage

Ryan Giffen, California State- Long Beach

Jeff Veenhuis, Surfacide

Make sure to follow along for future roundtables. We will also be checking out how the growing demand for shipping and logistics is spurring the next wave of automation on May 24th.

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More